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Welcome to the 2017 Clinical Investigators’ Day, sponsored by the Cornell University College of Veterinary 
Medicine. The primary goal of this forum is to provide an opportunity for residents and interns to showcase 
ongoing investigations carried out at Cornell University College of Veterinary Medicine. It is our hope that 
greater insights will be gained in the breadth and depth of clinical investigations conducted at the College 
and will serve as a catalyst to promote greater interactions among colleagues with clinical and basic science 
research interests.   
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Department of Molecular Medicine 
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Office of Research and Graduate Education 
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Current CVM Clinical Trials 
 
 
 
 
Dogs 
 
• Platelet-rich plasma in osteoarthritis 
• Prognosis in trauma and sepsis using cell-free 
DNA 
• Lymphoma tissue banking 
• Complement in IMHA 
• Epidural device to deliver pain relief 
• Cerenia™ as an adjunct analgesic 
• Monitoring pain and activity with electronic 
collar 
• New therapy for standard-of-care with 
osteosarcoma 
• New imaging techniques for degenerative 
myelopathy 
• Effect of Tranexamic Acid (TXA) following 
severe trauma 
• Evaluation of StablePlate RX™ in 
Thrombocytopenic canine patients 
• Biomarkers for pneumonia 
• Septic peritonitis and effusion biomarkers 
 
More dog trials in progress 
Cats 
 
• Carboplatin in injection site sarcomas 
• Phenobarbital effect on thyroid levels 
• Mammary cancer stem cells and cancer 
• Characterization of subgingival micro-
environment 
• Feline sepsis response 
• Sequencing studies of coronaviruses 
 
Horses 
 
• Improving recovery from anesthesia 
• Incisional complications following abdominal 
surgery 
• Medications in the treatment of gastric 
squamous ulcers disease 
 
 
 
For more information or to participate contact: 
 
vet-research@cornell.edu or call 
607.253.3279 
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Program Schedule 
 
Friday, October 6, 2017 
Lecture Hall 3, Veterinary Research Tower 
 
9:30 am – 10:00 am Morning Snack 
 
10:00 am – 10:15 am Welcome & Introductions – Dr. Erin Daugherity, DVM, MS, DACLAM 
 
10:15 am – 10:45 am Guest Presentation 
 
   Unraveling the Links Between Lipid Metabolism and Thrombosis in Dogs 
 
 Erica Behling-Kelly, DVM, PhD, DACVP; Assistant Professor. Cornell University, 
Department of Population Medicine and Diagnostic Sciences 
 
10:45 am – 11:45 am Resident Presentations – Moderated by Andrew Miller, DVM 
 
• Acute Myeloid Leukemia and Lymphoma in Dogs Produce Mediastinal Masses 
That Are Indistinguishable on Thoracic Radiographs 
 
Erin E. Epperly – Diagnostic Imaging Resident    Pg. 1 
 
• Retrospective Study of Factors Associated With Infections in Tibial Plateau 
Leveling Osteotomy in Dogs 
 
Daniel J. Lopez – Small Animal Surgery Resident   Pg. 2 
 
• Evaluation of Percutaneous Dilatational Tracheostomy in Dogs: 
An Experimental Manikin and Cadaver Study 
 
Mariana A. Pardo – Emergency and Critical Care Resident  Pg. 3 
 
• Effects of Oral Raltegravir in Cats With Experimentally-Induced Ocular 
and Respiratory Feline Herpesvirus-1 Infection 
 
Chloe B. Spertus – Ophthalmology Resident    Pg. 4 
 
11:45 am – 12:00 pm Break 
 
12:00 pm – 1:00 pm Resident Presentations – Moderated by Heidi Reesink, VMD, PhD 
 
• Serum Metabolomics of Endurance Alaskan Sled Dogs During Racing 
 
Lauri-Jo Gamble – Sports Medicine and Rehabilitation Resident  Pg. 5 
 
• The Effects of Maltodextrin and Protein Supplementation on Serum Metabolites 
in Exercising Competitive Weight-Pulling Dogs 
 
Hyun-tae Kim – Clinical Nutrition Resident    Pg. 6 
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Schedule (cont.) 
 
• Evaluation of Atipamezole as Treatment for Dexmedetomidine-Induced 
Cardiovascular Depression in Anesthetized Cats 
 
Katheryn K. Zatroch – Anesthesia Resident    Pg. 7 
 
• Pilot Study on Pharmacokinetics, Safety, and Clinical Efficacy of 
Cannabidiol Treatment in Osteoarthritic Dogs 
 
Lauri-Jo Gamble – Sports Medicine and Rehabilitation Resident  Pg. 8 
 
1:00 pm – 2:00 pm Lunch 
 
2:00 pm – 3:00 pm Resident Presentations – Moderated by Bryant Blank, DVM, MS, DACLAM 
 
• Plasma Amylase and Lipase Concentrations in Captive Black-Tailed 
Prairie Dogs (Cynomys Ludovicianus) 
 
Christina E. McCullough – Companion Exotics Intern   Pg. 9 
 
• Prevalence of Anticoagulant Rodenticide Exposure in Red-Tailed 
Hawks (Buteo Jamaicensis) in New York State and Diagnostic Utility of 
Russell Viper Venom Test for Detecting Associated Coagulopathies 
 
Cynthia R. Hopf – Zoological Medicine Resident   Pg. 10 
 
• Ethanol as an Alternative to CO2 for Euthanasia of Chickens 
(Gallus Gallus Domesticus) and Zebra Finches (Taeniopygia Guttata) 
 
Nathaniel S. Kollias – Laboratory Animal Medicine Resident  Pg. 11 
 
• Reference Intervals for Plasma Biochemical Parameters in Captive Black-Tailed 
Prairie Dogs (Cynomys Ludovicianus) Using Point-Of-Care Testing 
 
Christina E. McCullough – Companion Exotics Intern   Pg. 12 
 
3:00 pm – 3:15 pm Break 
 
3:15 pm – 4:15 pm Resident Presentations – Moderated by Erika Gruber-Hollingshead, DVM 
 
• Clinical and Radiographic Abnormalities Associated With Retained 
Tooth Roots in Dogs 
 
Kevin K. Ng – Dentistry and Oral Surgery Resident   Pg. 13 
 
• Syringobulbia in Dogs 
 
Baye G. Williamson – Neurology and Neurosurgery Resident  Pg. 14 
 
• Validation of an Equine Stall-Side Major Crossmatch Test 
 
Araba D. Bortsie-Aryee – Clinical Pathology Intern   Pg. 15 
 
vi 
 
Schedule (cont.) 
• Consequences of Subtherapeutic Antibiotic Environmental Contaminants in a 
Zebrafish (Danio Rerio) Model 
 
Rachael Labitt – Laboratory Animal Medicine Resident   Pg. 16 
 
4:15 pm – 5:00 pm Keynote Address 
 
Tick-Borne Disease: Translating Research to Clinical Diagnostics 
 
Dr. Laura Goodman, PhD; Senior Research Associate, Cornell University Department of 
Population Medicine and Diagnostic Sciences 
 
5:00 pm  Award Presentations 
 
   Dr. Lorin Warnick, DVM, PhD; Austin O. Hooey Dean of Veterinary Medicine 
 
Following Awards Reception (All Welcome!) 
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Keynote Speaker 
 
Dr. Laura B. Goodman, PhD; Senior Research Associate, Cornell University 
Department of Population Medicine and Diagnostic Sciences. 
 
Dr. Goodman is an emerging infectious disease researcher at the Cornell College of Veterinary 
Medicine, focusing on pathogen discovery, surveillance, and bridging the gap between research 
and diagnostics. She leads the development efforts in the Molecular Diagnostics section of the 
Cornell Animal Health Diagnostic Center / New York State Veterinary Diagnostic Lab. 
 
Her research investigates mechanisms of pathogen emergence and development of novel high-
throughput testing methods. Her thesis work established causal evidence of the connection of 
equine herpesvirus 1 neuropathogenicity with a viral mutation. Current focus areas in the lab are in emerging tick-
borne diseases and antimicrobial resistance. 
 
Dr. Goodman trained at the University of Michigan, Cornell, and Harvard and is an active member of the American 
Association of Veterinary Laboratory Diagnosticians. 
 
Guest Speaker 
 
Dr. Erica Behling-Kelly, DVM, PhD, DACVP; Assistant Professor Cornell University 
Department of Population Medicine and Diagnostic Sciences 
 
Dr. Behling-Kelly earned her DVM from the University of Georgia and her PhD from the 
University of Wisconsin, Madison where she also completed a residency in clinical pathology.  
 
She is interested in advancing our understanding of disease processes as well as improving our 
ability to diagnose disease. Her laboratory focuses on determining the pathogenic potential 
and diagnostic utility of serum lipoproteins in domestic species. In two of her on-going 
projects, she is investigating lipoproteins in the dog, relative to their ability to promote 
thrombosis in hyperlipidemic diseases (such as hyperadrencorticism) and the progression of renal disease. Another 
project is underway investigating changes in lipoproteins during various life-stages in dairy cows. She is also 
investigating the role of the erythrocyte and hemolysis in promoting thrombosis in the dog. 
  
Moderators 
 
Bryant Blank, DVM, MS, Dipl. ACLAM; Assistant Director, Agriculture Animals, 
Center for Animal Resources and Education (CARE) at Cornell University 
 
Dr. Blank is a clinical veterinarian at the Center for Animal Resources and Education (CARE). 
He received his DVM from Kansas State University in 2009. He then completed a three-year 
veterinary residency in laboratory animal medicine at Cornell University. During this period he 
received his MS in Comparative Biomedical Sciences working on the pathogenesis of Listeria 
monocytogenes. 
 
He currently provides clinical care for a variety of species, oversees multiple rodent vivaria, 
maintains regulatory oversight of large agricultural facilities, and assists in CARE’s residency training program and 
veterinary student rotations. He is involved in multiple research collaborations involving a diversity of species and 
fields, including reproductive physiology of the Giant Pouched Rat, safety assessment of a synthetic joint lubricant, 
patient derived tumor xenotransplantation novel treatment studies and welfare parameters associated with trio-
breeding of mice. 
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Moderators (cont.) 
 
Erika Gruber-Hollingshead, DVM; Graduate Student, Cornell University Department 
of Microbiology and Immunology 
 
Dr. Gruber graduated from the College of Veterinary Medicine at Cornell University in 2006. 
She completed a rotating internship in small animal medicine and surgery at Colorado State 
University in 2007, and then worked in small animal practice in Tennessee for three years. She 
returned to Cornell in 2010 for a residency in clinical pathology and was board-certified by the 
American College of Veterinary Pathologists in 2013. During her residency, Dr. Gruber 
conducted research on tissue factor-mediated thrombin generation by canine cancer cells. 
 
She is currently a graduate student in the Department of Microbiology & Immunology at Cornell, and is investigating 
how physical properties of the extracellular environment regulate macrophage response to inflammatory stimuli. Dr. 
Gruber is passionate about veterinary medicine, biomedical research, and maintaining a healthy work / life balance. 
 
Heidi Reesink, VMD, PhD, Assistant Professor of Large Animal Surgery, 
Cornell University Department of Clinical Sciences 
 
Dr. Reesink received her VMD from University of Pennsylvania in 2007 and completed a 
large animal residency at Cornell University in 2012.  She received her PhD in Comparative 
Biomedical Sciences from Cornell in 2016.  This same year she accepted the position of 
Assistant Professor in the Department of Clinical Sciences. 
 
Her laboratory aims to unravel basic mechanisms underlying the development of orthopedic 
disease and to pioneer innovative therapies for the treatment of joint injury and arthritis in 
equine and human athletes. Dr. Reesink’s clinical interests include large animal orthopedic surgery, equine sports 
medicine, lameness and emergency surgery. She is interested in translating novel research discoveries, including 
regenerative medicine, stem cell therapy, and lubricin therapy, to equine clinical patients with musculoskeletal disease. 
 
Andrew Miller, DVM; Assistant Professor and the Anne Groot Sesquicentennial Fellow, 
Department of Biomedical Sciences, Section of Anatomic Pathology, Cornell University 
College of Veterinary Medicine 
 
Dr. Miller earned his DVM degree from Cornell University and is board certified by the 
American College of Veterinary Pathologists (ACVP). He was an Assistant Professor and 
Comparative Pathologist at Harvard Medical School from 2008-2013 before his current 
position at Cornell University. 
 
His research interests focus on the pathogenesis and molecular alterations of intracranial 
neoplasia, soft tissue sarcoma, and hepatocellular carcinoma, predominately in the dog. Dr. Miller is also focused on 
studying the role that tumor-associated inflammation has in the progression and ultimate patient outcome in a variety 
of canine and feline neoplasms. In addition, he is co-director of the anatomic pathology residency program and is 
active nationally in the ACVP. 
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Judges 
 
Theodore G. Clark, PhD; Professor of Parasitology and Immunology, Cornell 
University Department of Microbiology and Immunology 
 
Dr. Clark joined the Department of Microbiology and Immunology in 1996 and is currently 
Director of the Graduate Field of Immunology and Infectious Disease. Dr. Clark received a 
BS from Columbia University, a PhD from the State University of New York at Stony Brook, 
and was a Postdoctoral Fellow in the Department of Biology at Yale University. 
 
Over the years, his research has been supported by grants from the National Institutes of 
Health, the National Science Foundation, the Department of Defense and the U.S. 
Department of Agriculture. He is a member of the Aquatic Animal Medicine Program in the College of Veterinary 
Medicine.  
 
Susan Fubini, DVM; Professor of Large Animal Surgery; Associate Dean for Academic 
Affairs, Cornell University Department of Clinical Sciences 
 
Dr. Fubini is a 1980 graduate of the University of Georgia, College of Veterinary Medicine.  
She completed a rotating large animal internship and surgical residency at Cornell University.  
 
She is currently a Professor of Large Animal Surgery and Associate Dean for Academic Affairs 
at the College of Veterinary Medicine, Cornell University. Dr. Fubini is a member of the 
American College of Veterinary Surgeons. Her clinical expertise is in large animal soft tissue 
procedures. She lives in Ithaca with her husband, Dr. Rory Todhunter, a small animal 
orthopedist, their four active children, and three unruly dogs. 
 
Dr. Hélène Marquis, DVM, PhD; Professor, Cornell University Department of 
Microbiology and Immunology  
 
Dr. Marquis received her DVM from the University of Montréal and worked as a small animal 
clinician before returning to academia. She completed a M.Sc. at the University of Montréal 
and a Ph.D. at Texas A&M University, both in veterinary microbiology. 
 
After finishing her post-doctoral training at the University of Pennsylvania, she assumed a 
faculty position at the University of Colorado, then moved to Cornell University. Dr. Marquis 
worked for many years on the pathogenesis of Listeria monocytogenes. More recently, her 
research has focused on fish health, disease, and nutrition. Actual projects include the effects of trace level antibiotics 
on intestinal microbiota, development of a phage-based diagnostic test for pathogenic Vibrio species, the use of insect 
larvae as a source of protein in fish feed, and skin mucus microbiota in health and disease. 
 
Scott Palmer, VMD; Adjunct Professor, Cornell University Department of Population 
Medicine and Diagnostic Sciences; New York State Equine Medical Director 
 
Dr. Palmer is a renowned veterinarian who, as the New York State Equine Medical Director, 
oversees the health and safety of horses at all New York State Thoroughbred and Standardbred 
racetracks. 
 
Since graduating from the University of Pennsylvania, School of Veterinary Medicine in 1976, 
Dr. Palmer has worked as a staff clinician at the New Jersey Equine Clinic, serving as the 
Hospital Director from 1997 through 2013. He is a two-time recipient of the New Jersey 
Equine Practitioners Veterinarian of the Year award, as well as a recipient of the AAEP President’s Award in 2009 
and the AAEP Distinguished Service Award in 2010. Dr. Palmer is board certified in equine practice by the American 
Board of Veterinary Practitioners and has authored dozens of peer-reviewed publications and is a featured speaker at 
veterinary conferences world-wide. 
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Judges (cont.) 
 
Mark Rishniw, BVSc, MS, PhD; Adjunct Professor, Cornell University Department of 
Clinical Sciences 
 
Dr. Rishniw received his BVSc from University of Melbourne in 1987 before completing an 
MS and residency in small animal internal medicine at Washington State University in 1994.  
He completed a cardiology residency at UC Davis in 1996 and then the Doctor of Philosophy 
from Cornell University in 2009. 
 
Dr. Rishniw was a Lecturer in Cardiology at Cornell and is board certified by both the 
American College of Veterinary Internal Medicine and the American College of Veterinary 
Internal Medicine (Cardiology). He has been Director of Clinical Research at VIN for the past 12 years, and is an 
adjunct professor at Cornell University. When not at work, Dr. Rishniw can usually be found on his bicycle. 
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 Erin Epperly, DVM 
eee36@cornell.edu  
Institution and Location 
Colorado State University, Ft. Collins, Colorado 
Cornell University, Ithaca, New York 
 
 
Current Position 
Resident, Diagnostic Imaging, 3rd Year 
Degree 
DVM 
Residency 
Year 
2007 
2015-Present 
 
Abstract Title: 
Acute Myeloid Leukemia and Lymphoma in Dogs Produce Mediastinal Masses That Are Indistinguishable on Thoracic 
Radiographs 
 
Authors Names: 
E. Epperly, K. R. Hume, S. Moirano, T. Stokol, J. Intile, H. Erb, P. V. Scrivani. Departments of Clinical Sciences (Epperly, 
Hume, Moirano, Scrivani) and Population Medicine & Diagnostic Sciences (Stokol, Erb), Cornell University, NY, 14853. 
Department of Clinical Sciences (Intile), North Carolina State University, NC, 27606 
 
Project Mentor: 
Peter V. Scrivani, DVM; Department of Clinical Sciences 
 
Abstract: 
Introduction/Purpose  
Acute myeloid leukemia (AML), an uncommon hematopoietic neoplasm of dogs, should be differentiated from lymphoma 
because of a worse prognosis for AML. Detecting a mediastinal mass during thoracic radiography often prioritizes lymphoma, 
but we have observed mediastinal masses in several dogs with AML. We hypothesized that dogs with AML more frequently 
have a mediastinal mass than dogs with lymphoid neoplasia, and that the size of the mass is larger in dogs with AML. 
 
Methods  
A blinded diagnostic accuracy study was performed using archived records of dogs with hematologic neoplasia and technically 
acceptable thoracic radiographs. Routine descriptive statistical analysis, non-parametric hypothesis testing, and basic accuracy 
measures were performed.    
 
Results  
The sample population encompassed 238 dogs. A mediastinal mass was detected during thoracic radiography in 73/218 (33%) 
and 9/20 (45%) dogs in the lymphoid and AML groups, respectively; the difference was not statistically significant (P=0.21). 
Dogs with AML also did not have a larger mediastinal mass than dogs in the lymphoid group, both qualitatively (P = 0.50) and 
quantitatively (P = 0.96). In the sample population, detection of a mediastinal mass during thoracic radiography was inaccurate 
for differentiating AML from lymphoid neoplasia (area under the ROC curve, 0.55). 
 
Discussion/Conclusion  
Our results show that cranial mediastinal masses are equally common in dogs with AML and lymphoma, and that AML cannot 
be differentiated based on size of the mass. Our results indicate that AML should be on the differential diagnosis list of dogs 
with mediastinal masses. 
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 Daniel J. Lopez, DVM 
djl242@cornell.edu  
Institution and Location 
Cornell University, Ithaca, New York 
Ontario Veterinary College, Guelph, Ontario, Canada 
Cornell University, Ithaca, New York 
 
Current Position 
Resident, Small Animal Surgery, 1st Year 
Degree 
DVM 
Intern 
Residency 
Year 
2016 
2016-2017 
2015-Present 
 
Abstract Title: 
Retrospective Study of Factors Associated With Infections in Tibial Plateau Leveling Osteotomy in Dogs 
 
Authors Names: 
Lopez DJ*, VanDeventer GM*, Krotscheck U, Aryazand Y, McConkey  
MJ, Hayashi K, Todhunter RJ, and Hayes G. 
 
*Co-first authors 
 
Project Mentor(s): 
Galina M. Hayes, BVSc, PhD, DVSc; Department of Clinical Sciences 
Rory J. Todhunter, BVSc, PhD; Department of Clinical Sciences 
 
Abstract: 
Introduction 
Surgical site infections (SSI) are an important complication secondary to TPLO procedures and carry both functional and 
financial consequences. 
 
Objective 
To identify preoperative and intraoperative risk factors associated with SSI in dogs undergoing TPLO, specifically evaluating 
preoperative dermatitis. 
 
Methods  
Records of 320 dogs undergoing unilateral or bilateral TPLO (n=405) between 2007 and 2015, that were examined by a 
veterinarian at least 8 weeks postoperatively, were evaluated for the development of an SSI.    
 
Results  
Of 405 procedures, 8.4% developed a SSI. 18% of procedures were performed on dogs with active dermatitis, and 3% of 
procedures were performed on patients with active dermatitis at the surgical site. SSI incidence in these two subgroups was 
10.2% (CI 4.5-21.3%, p=0.339) and 16.7% (95% CI=3.3-54.3, p=0.307) respectively. In univariable analysis, the German 
Shepherd Dog (GSD) was at 9.2 times greater odds of SSI compared to other breeds (95% CI=3.7-23.2, p<0.001). The highest 
risk surgeon had infection odds of 8.7 times greater compared with the lowest risk surgeon (95% CI=1.9-40.0, p=0.006). 
Additional significant risk factors identified included performing a meniscectomy (OR=2.07, 95% CI=1.03-4.15, p=0.04), 
surgical duration (OR=1.42, 95% CI=1.02-1.97, p=0.04) and body weight (OR=1.02, 95% CI=1.01-1.04, p=0.04). In a 
multivariable model, the association between GSD breed, performing a meniscectomy, and surgeon were retained. 
 
Discussion  
Identification of patients at increased risk for SSI allows for either targeted prophylactic antibiotic therapy or increased SSI 
monitoring and early intervention. Limitations of this study included underpowered analysis for cases with preoperative 
dermatitis and the retrospective nature of the study. 
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 Mariana A. Pardo, BVSc, MV 
map425@cornell.edu  
Institution and Location 
Universidad Mayor, Santiago, Chile 
University of Georgia, Athens, Georgia 
University of Florida, Gainesville, Florida 
Cornell University, Ithaca, New York 
 
Current Position 
Resident, Emergency and Critical Care, 3rd Year 
Degree 
BVSc, MV 
ECC Internship 
ECC Internship 
ECC Residency 
Year 
2009 
2013-2014 
2014-2015 
2015-Present 
 
Abstract Title: 
Evaluation of Percutaneous Dilatational Tracheostomy in Dogs: An Experimental Manikin and Cadaver Study 
 
Authors Names: 
Mariana A. Pardo1, Julia Sumner1, Adele Friello2, Daniel J Fletcher1, Robert Goggs1 
 
1Department of Clinical Sciences, Cornell University College of Veterinary Medicine, Ithaca, New York 
2College of Veterinary Medicine, Cornell University, Ithaca, New York 
 
Project Mentor(s): 
Robert Goggs; Cornell University, Department of Clinical Sciences, Ithaca, New York 
 
Abstract: 
Introduction 
Percutaneous dilatational tracheostomy (PDT) has become standard of care for tracheostomy tube placement in people and 
offers potential advantages over conventional surgical placement (ST). This study aimed to evaluate feasibility of PDT in dogs 
through assessment of procedure time, ease of placement and complication rates for PDT compared to ST. 
 
Methods  
A randomized crossover experimental manikin and cadaver study involving six novice veterinary students was performed. 
Each student performed 10 PDT and 10 ST procedures on a training manikin, followed by 2 PDT and 2 ST procedures in a 
canine cadaver. Bronchoscopy and observer feedback was provided. Finally, PDT and ST were performed in unused cadavers 
using new equipment. Placements were timed, ease of placement scored using visual analog scales (VAS) and complications 
assessed by observers using ordinal scales (0-3). Cadaver tracheas were explanted post-procedure to evaluate anatomical 
damage scores (0-3). Time taken and VAS scores for ST and PDT procedures were analyzed using mixed-effects linear models, 
accounting for student, technique, and procedure number with post-hoc pairwise comparisons.    
 
Results  
Data are presented as median (range). For the final cadaver placement, there were no significant differences in placement time 
188s (116-414) vs 300s (230-1020) (P=0.210), ease of placement 19mm (0-47) vs 38mm (21-57) (P=0.132), anatomical damage 
score 0 (0-1) vs 1 (0-2) (P=0.063), or equipment complications score 0 (0-0) vs 0 (0-1) (P=1.000) between ST and PDT 
respectively. 
 
Conclusion  
PDT can be performed as quickly, easily and safely as ST in canine cadavers by novice veterinary students. 
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 Chloe B. Spertus, DVM 
cbs259@cornell.edu  
Institution and Location 
Cornell University, Ithaca, New York 
University of Missouri, Columbia, Missouri 
Cornell University, Ithaca, New York 
 
Current Position 
Resident, Comparative Ophthalmology, 2nd Year 
Degree 
DVM 
Rot. Internship 
Residency 
Year 
2015 
2016 
2016-Present 
 
Abstract Title: 
Effects of Oral Raltegravir in Cats With Experimentally-Induced Ocular and Respiratory Feline Herpesvirus-1 Infection 
 
Authors Names: 
Chloe B. Spertus1, Matthew R. Pennington2, Gerlinde R. Van de Walle2, Zachary I. Badanes1, Bonnie E. Judd1, 
Hussni O. Mohammed3, Eric C. Ledbetter1 
 
1Department of Clinical Sciences, Cornell University, Ithaca, NY 
2Baker Institute for Animal Health, Cornell University, Ithaca, NY 
3Department of Population Medicine and Diagnostic Sciences, Cornell University, Ithaca, NY 
 
Project Mentor(s): 
Eric C. Ledbetter, DVM, DACVO; Department of Clinical Sciences 
 
Abstract: 
To determine the effects of oral raltegravir (Isentress®, Merck & Co., Kenilworth, New Jersey) treatment in cats with 
experimentally-induced ocular and respiratory feline herpesvirus-1 (FHV-1) infection.  
 
A randomized, masked, vehicle-controlled, 30-day trial was performed using 14 nonvaccinated specific-pathogen-free cats with 
experimental FHV-1 infection induced by topical ocular inoculation. Cats received oral raltegravir (80mg) or vehicle (lactulose) 
capsules by mouth, twice daily, for 14 days. Cats were monitored after inoculation for 30 days. Ophthalmic examinations were 
performed every two days and ocular disease scores were calculated. Sneezing and nasal discharge were scored and respiratory 
rates were assessed every two days. Ocular samples for FHV-1 qPCR and virus isolation assays were collected every 3 days.  
 
After inoculation, all cats developed ocular and respiratory disease typical of primary FHV-1 infection, including conjunctivitis 
and corneal ulceration. Using regression analysis, the raltegravir treatment group had significantly lower ocular disease scores, 
respiratory disease scores, and respiratory rates over time compared to the vehicle treatment group. The median duration of 
ocular viral shedding was significantly shorter in the raltegravir group compared to the vehicle group. Although the raltegravir 
treatment group had lower ocular viral loads in comparison to the vehicle treatment group, the difference was not statistically 
significant. Hemogram and serum biochemistry panel values were unremarkable throughout the study.  
 
Oral raltegravir, administered twice daily, may be a viable treatment option to alleviate the ocular and respiratory clinical signs 
associated with FHV-1 infection in cats. Supported by the Foundation for Ophthalmology Research and Education 
International.  
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 Lauri-Jo Gamble, DVM, CCRP 
lg497@cornell.edu  
Institution and Location 
Montreal University, St-Hyacinthe, Canada 
Carolina Veterinary Specialists, Charlotte, North Carolina 
VOSM, Annapolis Junction, Maryland 
Cornell University, Ithaca, New York 
 
Current Position 
Resident, Sports Medicine and Rehabilitation, 2nd Year 
Degree 
DVM 
Internship 
Spec. Internship 
Residency 
Year 
2014 
2015 
2016 
2016-Present 
 
Abstract Title: 
Serum Metabolomics of Endurance Alaskan Sled Dogs During Racing 
 
Authors Names: 
Lauri-Jo Gamble1, Christopher W. Frye1, Cristina M. Hansen2, Nicholas Berthelsen1, Jason W. Locasale3, Xiaojing Liu3, 
Joseph J. Wakshlag1 
 
1Cornell University, College of Veterinary Medicine, Ithaca, New York 
2University of Alaska, Fairbanks, Alaska 
3Duke University School of Medicine, Durham, North Carolina 
 
Project Mentor(s): 
Joseph J. Wakshlag, DVM, PhD, ACVN, ACVSMR; Department of Clinical Sciences (Mentor) 
Christopher W. Frye, DVM; Department of Clinical Sciences (Co-mentor) 
 
Abstract: 
Lipid metabolism has long been thought to be the major substrate involved in sled dogs endurance racing. However, a 
recent study suggests that they are equally, if not more, dependent on carbohydrate metabolism. Considering the metabolic 
disparity, our study aimed to explore the serum metabolomic profiles of sled dogs running a 1000-mile race. We 
hypothesized that there would be depletion of amino acids involved in the repletion of the citric acid cycle due to need for 
gluconeogenesis.   
 
Serum was obtained and frozen until analyzed from 6 Alaskan sled dogs 24 hours prior to the race, at the midrace 
checkpoint (480 miles), and again at the finish (983 miles). After thawing, serum samples were prepared for liquid 
chromatography-mass spectrometry for over 240 metabolites involved in amino acid, lipid, and carbohydrate metabolism. 
MetaboAnalyst Software 3.0 was then used to analyze data using one-way repeated measures analysis of variance across all 
metabolites with corrections for false discovery rate.  
 
Major metabolic changes observed were enhanced acyl-carnitine derivatives compared to baseline, and depletion of nearly 
all amino acids except for hepatic bypass branched-chain amino acids, which were not different from baseline and were 
possibly enhanced. Many of the citric acid cycle intermediates exhibited variable increases and decreases. Depletion of 
nearly all amino acids, except for hepatic bypass branched chain amino acids suggest that sled dogs are reliant, at least 
partially, on protein and carbohydrate during exercise. The increases in carnitine bound fatty acid derivatives suggest a 
potential rate limiting beta-oxidation during endurance exercise. 
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 Hunter (Hyun-tae) Kim, DVM, MS 
hk894@cornell.edu  
Institution and Location 
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Abstract: 
Post-exercise carbohydrate repletion of skeletal muscle utilizing maltodextrin, with or without highly digestible protein, is 
documented to improve performance in humans.  However, there is limited evidence in improved performance other than 
elevations in muscle glycogen and serum amino acid responses. The objectives of this study were two-fold; 1) to examine the 
metabolomic changes associated with a competitive weight pulling; and 2) to examine the effects of maltodextrin/protein 
supplementation on serum metabolomics during recovery. 
 
Serum was collected from 12 dogs (6 control and 6 treatment) at different time points (pre-exercise, post-exercise, 30 minutes 
post, 3 hours post) and Liquid Chromatography-Mass Spectrometry (LC-MS) was performed for approximately 242 
metabolites. Serum glucose and insulin concentrations were also evaluated by the Cornell Diagnostic Laboratory. A two-way 
ANOVA for time and treatment with false discovery rate corrections was used by Metaboanalyst 3.0.  
 
There were 9 metabolites found to be significantly increased or decreased after exercise from baseline representing primarily 
citric acid cycle metabolites. Treatment differences at 30 minutes showed 8 metabolites including amino acids and 
carbohydrate intermediates were elevated with supplementation. Twenty-eight metabolites were significantly different at 3 
hours post-exercise, with most metabolites being related to increases in amino acids and related metabolites, as well as 
suppression of fatty acid metabolites with supplementation. 
 
Although serum insulin and glucose showed no differences between treatment groups there are definite alterations in 
metabolites suggesting that post-supplementation with maltodextrin and protein support glucose metabolism and depress fatty 
acid metabolism during recovery from a simulated weight pulling event. 
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Abstract: 
Introduction  
Dexmedetomidine is a sedative agent frequently used for anesthesia in cats. One disadvantage is that it reduces heart rate (HR) 
and cardiac output (CO) by up to 50% and produces arterial hypertension. The α2-antagonist agent atipamezole can shorten 
anesthetic recovery and raise HR in awake cats. Since atipamezole produces vasodilation, this effect might be augmented in the 
presence of volatile anesthetics. Moreover, since general anesthetics alter the baroreflex, a reflexive increase in HR may also be 
blunted. 
 
Objective 
To evaluate the hemodynamic effects of two doses of atipamezole administered intramuscularly (IM) to anesthetized cats 
receiving dexmedetomidine. 
 
Methods  
6 purpose-bred cats were anesthetized 3 times with isoflurane. Dexmedetomidine 5 µg/kg was administered IV. Ten minutes 
later, either saline or atipamezole (25 or 50 µg/kg) was administered IM. The HR, direct mean arterial pressure (MAP), and 
CO were recorded at baseline, at peak effect after dexmedetomidine, at peak effect after treatment, and 15, 30, 60, 120 minutes 
post-treatment.    
 
Results (partial) 
3 cats have completed all treatments. Compared with saline, atipamezole resulted in lower HR and MAP. Arterial hypotension 
(MAP<60 mmHg) was observed 5/6 times after atipamezole but none after saline. The CO did not improve compared with 
saline. 
 
Conclusion  
Atipamezole causes substantial vasodilation but only minimal improvement in HR and CO when administered under general 
anesthesia in cats. These preliminary results raise awareness of the potential deleterious consequences of using atipamezole to 
treat dexmedetomidine-induced cardiovascular depression under general anesthesia. 
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Abstract: 
In the absence of an ideal treatment for chronic pain associated with osteoarthritis, there is an interest for cannabinoid 
derivatives, yet minimal scientific evidence regarding efficacy or safety in dogs. The objectives of this ongoing study were to 
determine the (1) basic oral pharmacokinetics, (2) general short term safety, and (3) efficacy of a novel cannabidiol extract 
(CBD) in dogs with multi-joint osteoarthritis.  
 
A basic 24-hour oral pharmacokinetic study was performed at 2 different dosages (2mg/kg and 8mg/kg). Thereafter, sixteen 
client-owned dogs completed a placebo-controlled double-blind cross-over study. Dogs were randomly receiving CBD oil 
(2mg/kg ml/kg q12) or placebo oil for 4 weeks with 2 weeks washout period before cross-over. Veterinary assessments as well 
as owner questionnaires were completed at weeks 0, 2, and 4 for both oils. 
 
Oral pharmacokinetics showed that half-life of elimination was 4.7 ± 1.2 hours with a 2 mg/kg dose. No obvious psychoactive 
properties were observed on neurological evaluation at any time point. On the clinical assessment, CBPI and Hudson scores 
showed a significant decrease in pain and increase in activity (p ≤ 0.01) at week 2, while only Hudson activity indices were 
improved at week 4 for CBD oil (p ≤ 0.01). ALP increased over time for 8 dogs while receiving CBD oil, reaching significance 
at week 4 (p ≤ 0.01). We conclude that dogs with osteoarthritis receiving CBD oil are perceived to be more comfortable and 
active with very few undesirable side effects detected when compare to a placebo oil. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
9 
 
 Christina McCullough, DVM, MLAS 
cem357@cornell.edu  
Institution and Location 
Drexel University, Philadelphia, Pennsylvania 
The Ohio State University, Columbus, Ohio 
Kansas State University, Manhattan, Kansas 
 
Current Position 
Intern. Companion Exotics, Wildlife and Zoo medicine 
Degree 
MLAS 
DVM 
Internship 
Year 
2012 
2016 
2017 
 
Abstract Title: 
Plasma Amylase and Lipase Concentrations in Captive Black-Tailed Prairie Dogs (Cynomys Ludovicianus) 
 
Authors Names: 
C. McCullough1, D. Eshar1, T. L. Wright1, L.M. Pohlman2 
 
1Department of Clinical Sciences, College of Veterinary Medicine, Kansas State University, Manhattan, Kansas 
2Department of Diagnostic Medicine and Pathobiology, College of Veterinary Medicine, Kansas State University, Manhattan, Kansas 
 
Project Mentor(s): 
Dr. David Eshar; Kansas State University, Manhattan, Kansas 
Ricardo de Matos; Cornell University, Ithaca, New York 
 
Abstract: 
Introduction  
The black-tailed prairie dog (Cynomys ludovicianus) is one of five species of prairie dogs, a keystone species in the grasslands of 
North America. They are kept in zoological collections, research facilities, and as privately-owned pets. This herbivorous, 
burrowing animal is a member of the order Rodentia and the family Sciuridae. Although several studies have described 
hematologic and physiologic parameters in the black-tailed prairie dog, none have reported amylase or lipase concentrations in 
this species. 
 
Objective 
This study was conducted to determine plasma amylase and lipase concentrations in captive black-tailed prairie dogs. 
 
Methods  
Twenty-six healthy, captive prairie dogs of both sexes were studied as part of an overall health evaluation performed under 
isoflurane anesthesia. Each animal underwent a physical examination, complete blood count, plasma biochemistry, and blood 
gas analysis. Venous samples were placed in heparinized blood tubes and were submitted for analysis. The amylase and lipase 
enzymatic colorimetric assays were used to obtain a quantitative measurement of plasma enzyme concentrations by an 
automatic wet biochemistry analyzer. Data analysis was performed according to the guidelines published by the American 
Society for Veterinary Clinical Pathology.    
 
Results 
The reference interval for amylase was 111.3-499.1 IU/L, and the mean and median plasma amylase concentration were 323.2 
IU/L and 341 IU/L respectively (min=152 IU/L, max=481 IU/L). The reference interval for lipase was 25.7-78.4 IU/L, and 
the mean and median plasma lipase concentration were both 49.5 IU/L (min=27 IU/L, max=80 IU/L). The new data 
presented in this report can promote better physiological understanding and improve clinical management of this species. 
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Abstract: 
Introduction 
Free-ranging red-tailed hawks (Buteo jamaicensis) are commonly exposed to anticoagulant rodenticides (ARs) through 
contaminated prey. Coagulation tests suitable for detecting AR-related coagulopathy in raptors are not routinely available, 
potentially resulting in underdiagnosed AR-related coagulopathy.   
 
Objective 
The aims of this study were to assess the prevalence of AR exposure in free-ranging B. jamaicensis in New York State (NYS), 
and investigate Russell’s viper venom time (RVVT) as an affordable, practical coagulation test. Blood was collected from a 
control group of B. jamaicensis (n=14) and a study group of sick B. jamaicensis presented to the Cornell University Wildlife 
Health Center (n=39). Liver was collected from a subset of hawks. A toxicology screen as performed to detect AR 
compounds, and two clotting time tests to identify coagulopathies: prothrombin time (PT), and RVVT.  
 
Results 
Of the 35 birds tested, 12 (34%), had detectable AR concentrations in liver (brodifacoum in 11/12 (92%); difethialone in 1/12 
(8%)) or blood (brodifacoum in 2/35 (6%)). Birds with detectable AR concentrations had clotting times not different from 
controls. Birds without detectable concentrations had shorter PT (P<0.004) but not RVVT (P=0.06). The RVVT and PT 
correlated in the birds tested (rho=0.6).  Using a reference threshold of 40sec for PT, and 50sec for RVVT, RVVT was 
sensitive, but non-specific for detecting coagulopathies.  Birds with markedly prolonged RVVT (>100sec) are likely 
coagulopathic. RVVT might provide a practical test to rule out AR exposure, but prolonged RVVT test results warrant 
additional testing, in a population of raptors still highly exposed to AR. 
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Abstract: 
Injectable pentobarbital and inhalant CO2 are the current ‘acceptable’ and ‘acceptable with conditions’ for euthanasia of avian 
species. However, barbiturates are controlled substances and thus challenging to use in the field and laboratory setting. 
Additionally, there is limited literature on the use of CO2 in avian species and flow rates are extrapolated from mammalian 
studies. Ethanol is a potential alternative euthanasia agent due to its pharmacological properties and accessibility. We 
hypothesized that ethanol would be equivalent or superior to pentobarbital as a means of euthanasia in chickens (Gallus gallus 
domesticus) and zebra finches (Taeniopygia guttata). Birds were randomized into three groups, receiving either 100% ethanol, 
saline, or pentobarbital intracoelomically, and all chickens were monitored with ECG, capnography, and pulse oximetry. 
Chickens receiving either pentobarbital or ethanol both exhibited a smooth transition into a surgical plane of anesthesia, with 
5/7 ethanol birds declared euthanized at approximately 10 minutes, and 5/7 pentobarbital birds declared euthanized at 
approximately 7 minutes following injection. In chickens euthanized by ethanol, loss of respiration occurred prior to cardiac 
arrest, which was confirmed by capnography following loss of consciousness. In zebra finches, 16/17 (ethanol) and 16/17 
(pentobarbital) were euthanized in <5 minutes post injection. Neither species in the ethanol and pentobarbital groups 
exhibited overt signs of distress. In summary, the data suggests 100% ethanol is equivalent and/or superior to pentobarbital 
because it quickly and repeatedly induces a smooth anesthetic induction, results in minimal to no signs of distress, and achieves 
a deep plane of anesthesia prior to death. 
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Abstract: 
Introduction  
The black-tailed prairie dog (Cynomys ludovicianus) is an herbivorous member of the family Sciuridae of the order Rodentia. This 
species serves as a common research model, collection animal, and privately-owned pet. As the popularity of the prairie dog 
increases, the need for validated reference ranges grows. 
 
Objective 
This prospective study was conducted to establish reference intervals for biochemical parameters in clinically healthy, captive 
black-tailed prairie dogs using point-of-care testing according to ASVCP guidelines. We hypothesized that biochemical analytes 
would be influenced by both age and gender. A specific goal was to determine if agreement of biochemical parameters exists 
between two analyzers: the VetScan (VS2) and the Cobas c501. We hypothesized no agreement would exist between the two 
testing methodologies. 
 
Methods  
Forty-one captive black-tailed prairie dogs were used: 16 females and 25 males varying in age were studied as part of an overall 
health evaluation performed under anesthesia. Venous samples were collected and placed in heparinized tubes for analysis. 
This study utilized the VS2 point-of-care analyzer, recording 14 biochemical analytes on the Comprehensive Diagnostic 
Profile.    
 
Results 
Eight biochemical analytes were influenced by age. Glucose, BUN, Phosphorus and ALP were significantly lower in older 
animals. Total Protein, Globulin, Sodium, and Total Bilirubin were significantly higher in older animals. Two biochemical 
analytes were influenced by gender. Albumin and Creatinine were both significantly higher in females. Agreement statistics 
between the Cobas c501 and VS2 determined that there was statistically significant bias. Only 3 analytes, BUN, Calcium and 
Sodium, had agreements that were within clinical allowable error limits. 
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Abstract: 
Introduction  
Retained tooth roots (RTR) are common in dogs, and are believed to predispose to apical periodontitis, draining tracts, and 
local swelling. The objectives of this study were to describe the clinical and radiographic findings associated with RTR in dogs, 
and determine whether RTR dimensions and relative location are associated with abnormal clinical and radiographic findings. 
We hypothesized that larger RTR, and RTR that protrude through the alveolar bone, are more likely to cause abnormalities. 
 
Materials and Methods  
39 dogs diagnosed with at least 1 RTR based on clinical and radiographic assessment were included in this study. The length 
and width of each RTR present was measured digitally. The location of each RTR in relation to the alveolar margin was 
recorded. Radiographic evidence of marginal or apical periodontitis was recorded. The associated gingiva was inspected for the 
presence of inflammation, draining tracts or visibility of the retained root fragment. Variables were compared to establish 
possible associations.    
 
Results 
The mean number of RTR per dog was 2.4 (median: 2, range: 1-13). The mean length and width of RTR identified were 
6.6±3.6mm and 2.7±1.2mm, respectively. The most frequently affected teeth were the premolars (58%). Overall, abnormal 
findings were present in 52.1% of RTR. For every 1-mm increase in length of RTR, the odds of finding either abnormal 
radiographic or clinical findings increased by a factor of 1.26 (95% CI: 1.09-1.5; p < 0.01). 
 
Conclusions 
Abnormal clinical or radiographic findings were present in the majority of RTR. Longer roots were more likely to cause clinical 
and radiographic abnormalities. 
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Abstract: 
Introduction  
Craniocervical junction abnormalities can result in a physical constriction of the foramen magnum. This causes pressure 
changes and alters the cerebrospinal fluid flow (CSF) making it turbulent, which results in syringomyelia. In humans with 
syringomyelia, syringobulbia, a fluid-filled cavity in the medulla usually communicating with the lumen of the fourth ventricle, 
is a rare sequela. Currently, there are no reports in veterinary literature describing syringobulbia in dogs. 
 
Objective 
To describe the clinical presentation, disease progression, magnetic resonance imaging (MRI) findings and outcomes of dogs 
with presumptive syringobulbia. 
 
Methods  
A retrospective case series from 2012 to 2017 identified four canine cases with craniocervical junction abnormalities and 
syringobulbia that had been diagnosed via MRI.    
 
Results 
Four dogs presented with neurologic signs consistent with central vestibular disease and 3/4 dogs presented acutely. Age of 
presentation was 13 months to 107 months; however, in the dog that presented at 107 months, vestibular signs had been 
slowly progressive since 4-months of age. MRI findings in all cases initially demonstrated ipsilateral slit-like or bulbous CSF-
filled cavities of the myelencephalon. One dog, on repeat MRI, demonstrated disease progression resulting in an additional 
unilateral hypoglossal neuropathy contralateral to the original syringobulbia lesion. In 2 of the 4 dogs, medical management 
was elected with a combination of steroids, pain medication and proton pump inhibitors; the other 2 dogs had surgery to 
address their clinical signs. 
 
Conclusions 
Syringobulbia occurs in dogs and medical or surgical management may be acceptable options depending on the individual case 
presentation and disease progression. 
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Abstract: 
Blood transfusion is a vital tool in equine critical care, necessary for the treatment of severe anemia due to blood loss and 
hemolysis. A blood transfusion between incompatible horses can cause transfusion reactions, which can be life-threatening. A 
cross-match can be done prior to a blood transfusion to assess compatibility, however, the currently used standard of 
laboratory crossmatch procedure is time consuming, costly, requires technical expertise and is not readily available to the 
equine practitioner. A new stall-side gel crossmatch kit has been developed for horses. However, this kit has not been 
independently validated. If this kit can identify blood type incompatibilities, it would allow veterinarians to find appropriate 
blood donors, thus permitting safe blood transfusion in the field.  
 
Our goal is to determine the sensitivity and specificity of a stall-side crossmatch kit in comparison to the current laboratory 
standard. Blood from 11 horses at the Cornell Equine Research Park that have already been blood typed and antibody 
screened, will be used in this study. We will perform crossmatch combinations of the horses’ serum and red blood cells to yield 
predicted strong and weak positive as well as negative reactions. Crossmatches will be performed on the same day by blinded 
investigators and independently verified. Results will be scored categorically using standard criteria.  
 
We expect the stall-side test will be fast and easy to perform and will be able to detect incompatible crossmatches with both 
weak and strong reactions on the laboratory gold standard. 
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Abstract: 
Antibiotic resistance is an increasing threat to human and animal health. Antibiotics are found within water sources throughout 
the world, since most antibiotics are excreted unmetabolized. Despite being found in levels too low to inhibit growth in vitro, 
subtherapeutic levels of antibiotics are not innocuous: they promote biofilm formation, mutagenesis, alterations of metabolism 
and virulence, and resistance. Preliminary experiments show that the mean inhibitory concentration calculated in vitro is higher 
than the concentration needed to inhibit growth in in vivo models, demonstrating a need for in vivo aquatic models of 
antibiotic exposure. We hypothesize that zebrafish (Danio rerio) exposed chronically to subtherapeutic levels of antibiotics will 
show effects of antibiotic exposure, including decreased gut microbiota, increased bacterial resistance, and increased 
colonization with pathogenic bacteria. We will investigate antibiotics of human and veterinary importance (ciprofloxacin, 
erythromycin, and sulfamethoxazole) at concentrations observed contaminating natural waterways. Zebrafish will be 
maintained in water treated or not with antibiotics for eight weeks duration. Every two weeks, a subset of fish will be 
euthanized and the intestines harvested. Microbiota content and proportion of resistant bacteria will be assessed by plating and 
qPCR. Fish with chronic antibiotic exposure will be challenged with the zebrafish pathogen Vibrio parahaemolyticus or the 
human pathogen Vibrio cholera, and colonization will be measured by bacterial isolation and PCR identification. We seek to 
determine if chronic exposure to subtherapeutic doses of antibiotics has adverse effects on intestinal microbiota, emergence of 
resistance, and susceptibility to pathogens that threaten both aquatic life and public health. 
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